Jul 13, 2016 - Immuno-oncology focused Juno (JUNO) remained in the news with the FDA first placing a clinical hold on a pivotal study and then removing it.
Jul 14, 2016 - The Zacks Analyst Blog Highlights: Juno, Amgen, AbbVie, Gilead and CytRx
Jul 14, 2016 - Amgen (AMGN) inked an exclusive agreement with Daiichi Sankyo for the commercialization of nine biosimilars in Japan.
Jul 26, 2016 - Alexion Pharmaceuticals (ALXN), which is set to report second-quarter 2016 results on Jul 28, had delivered a negative earnings surprise of 4.40% last quarter.
Jul 25, 2016 - Celgene Corporation (CELG), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.38% last quarter.
Jul 25, 2016 - Bristol-Myers Squibb (BMY), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.12% last quarter.
Jul 26, 2016 - Focus will remain on the performance of ARIAD's (ARIA) leukemia drug, Iclusig.
Jul 21, 2016 - The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21, 2016 - The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
Jul 21, 2016 - Sharp growth in Microsoft’s cloud computing business helped both the Dow and the S&P 500 to close at fresh record highs on Wednesday